genedrive plc announces that initial orders of the Genedrive® MT-RNR1 products have been received from France, Austria, Greece, Saudi Arabia, Turkey and the Netherlands. This follows the Company recently confirming that commercial distribution agreements for the genedrive test for antibiotic induced hearing loss ("AIHL") in a number of countries had been signed. The initial orders will support genedrive's international distribution partners in promotion and in-country evaluation activities in their respective countries, to provide more extensive access to this life-changing test.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 GBX | 0.00% | -28.21% | -56.92% |
24/04 | Genedrive enters clinical trial deal in US for MT-RNR1 US approval | AN |
03/04 | FTSE 100 up thanks to US economic data | AN |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.92% | 6.26M | |
-15.43% | 18.51B | |
-40.81% | 2.85B | |
+19.34% | 1.95B | |
+2.22% | 1.72B | |
+28.27% | 1.26B | |
-9.56% | 1.02B | |
-16.29% | 950M | |
+0.07% | 777M | |
-22.49% | 643M |
- Stock Market
- Equities
- EHP Stock
- News genedrive plc
- Genedrive plc Announces Initial Overseas Orders of Mt-RNR1 Id Kit